HCW Biologics (HCWB) News Today $0.36 -0.02 (-6.13%) Closing price 04:00 PM EasternExtended Trading$0.34 -0.01 (-3.84%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period FDA approves HCW Biologics trial for alopecia treatmentFebruary 3, 2025 | msn.comHCW Biologics receives clearance of IND from FDA for HCW9302February 3, 2025 | markets.businessinsider.comPharma company granted FDA clearance for alopecia drug studyFebruary 3, 2025 | bizjournals.comHCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical TrialFebruary 3, 2025 | markets.businessinsider.comHCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical TrialFebruary 3, 2025 | globenewswire.comHCWB stock touches 52-week low at $0.25 amid market challengesJanuary 30, 2025 | msn.comHCW Biologics Insiders Placed Bullish Bets Worth US$2.50mJanuary 23, 2025 | finance.yahoo.comHCW Biologics CEO to address opportunities, challenges in biomanufacturingJanuary 15, 2025 | markets.businessinsider.comHCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025January 15, 2025 | globenewswire.comHCW Biologics receives notice on failing to regain compliance from NasdaqDecember 23, 2024 | markets.businessinsider.comBroward pharma business could be delisted from stock exchangeDecember 23, 2024 | bizjournals.comHCW Announces Written Notice from NASDAQDecember 23, 2024 | baystreet.caHCW Biologics Inc. Receives Nasdaq Delisting Notice, Plans to Appeal for Continued ListingDecember 23, 2024 | quiverquant.comHCW Biologics Inc. Received NASDAQ Staff Determination LetterDecember 23, 2024 | globenewswire.comHCW Biologics Secures Strategic Agreements and Funding to Propel Growth and InnovationNovember 28, 2024 | markets.businessinsider.comHCW Biologics issues 2.55 million shares to Armistice CapitalNovember 26, 2024 | investing.comHCW Biologics Expands with New Financial AgreementsNovember 21, 2024 | markets.businessinsider.comHCW Biologics jumps on license agreement for immunotherapeutic product candidateNovember 19, 2024 | msn.comHCW Biologics licenses proprietary preclinical molecule to WY BiotechNovember 19, 2024 | markets.businessinsider.comWhy Is Penny Stock HCW Biologics Surging On Monday?November 19, 2024 | finance.yahoo.comHCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ RulesNovember 18, 2024 | globenewswire.comHCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product CandidateNovember 18, 2024 | globenewswire.comHCW Biologics, Inc: HCW Biologics Reports Third Quarter 2024 Financial Results and Business HighlightsNovember 16, 2024 | finanznachrichten.deHCW Biologics Reports Third Quarter 2024 Financial Results and Business HighlightsNovember 14, 2024 | globenewswire.comHCW Biologics (NASDAQ:HCWB) Stock, Insider Trading ActivityOctober 1, 2024 | benzinga.comHCW Biologics (NASDAQ:HCWB) Stock Quotes, Forecast and News SummaryOctober 1, 2024 | benzinga.comAC Immune SA (IMR.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 24, 2024 | finance.yahoo.comHCWB HCW Biologics Inc.August 25, 2024 | seekingalpha.comHCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - CorrectionAugust 23, 2024 | globenewswire.comHCW Biologics, Inc: HCW Biologics Reports Second Quarter 2024 Financial Results and Business HighlightsAugust 15, 2024 | finanznachrichten.deHCW Biologics Reports Second Quarter 2024 Financial Results and Business HighlightsAugust 14, 2024 | globenewswire.comHCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024May 15, 2024 | investorplace.comHCW Biologics Warns of Ability to Continue Operating Without Additional FundsMay 15, 2024 | marketwatch.comHCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsMay 15, 2024 | markets.businessinsider.comHCW Biologics Reports First Quarter 2024 Financial Results and Business HighlightsMay 15, 2024 | globenewswire.comHCW Biologics Inc. (NASDAQ:HCWB) Short Interest UpdateHCW Biologics Inc. (NASDAQ:HCWB - Get Free Report) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 22,000 shares, a drop of 8.3% from the February 29th total of 24,000 shares. Based on an average daily volume of 16,700 shares, the days-to-cover ratio is presently 1.3 days. Currently, 0.1% of the company's stock are short sold.April 2, 2024 | marketbeat.comHCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023April 2, 2024 | investorplace.comHCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business HighlightsApril 1, 2024 | globenewswire.comHCW Biologics Inc. (NASDAQ:HCWB) Sees Large Growth in Short InterestHCW Biologics Inc. (NASDAQ:HCWB - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 29th, there was short interest totalling 24,000 shares, an increase of 445.5% from the February 14th total of 4,400 shares. Based on an average daily volume of 14,500 shares, the short-interest ratio is presently 1.7 days. Currently, 0.2% of the company's stock are sold short.March 12, 2024 | marketbeat.comRebecca Byam Bought 122% More Shares In HCW BiologicsFebruary 24, 2024 | finance.yahoo.comSeveral Insiders Invested In HCW Biologics Flagging Positive NewsJanuary 25, 2024 | finance.yahoo.comHCW Biologics Receives Buy Rating: Strong Financial Position and Promising Clinical Data Validate Investment OpportunityNovember 17, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: HCW Biologics (HCWB), Urogen Pharma (URGN)November 15, 2023 | markets.businessinsider.comHCW Biologics, Inc: HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNovember 14, 2023 | finanznachrichten.deHCW Biologics GAAP EPS of -$0.14, revenue of $174.77MNovember 14, 2023 | msn.comHCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business HighlightsNovember 14, 2023 | finance.yahoo.comADMA Biologics Inc ADMANovember 11, 2023 | morningstar.comHCW Biologics Inc HCWBNovember 11, 2023 | morningstar.comPromising Phase 1 Results and Potential Synergies with PD-1 Inhibitors Bolster Buy Rating for HCW BiologicsNovember 11, 2023 | markets.businessinsider.comInvestigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual MeetingNovember 8, 2023 | finance.yahoo.com Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address HCWB Media Mentions By Week HCWB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCWB News Sentiment▼0.440.70▲Average Medical News Sentiment HCWB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCWB Articles This Week▼20▲HCWB Articles Average Week Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Clearside Biomedical News Today Mural Oncology News Today Aligos Therapeutics News Today Applied Therapeutics News Today vTv Therapeutics News Today GRI Bio News Today Context Therapeutics News Today 23andMe News Today Forte Biosciences News Today Quince Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HCWB) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
